After a month of intensive preparations I can now finally announce that I will leave my current employer on July 27, 2012, and on the following Monday I will open the books on Dirk Rodgers Consulting, LLC. As many of you know, I have filled the role of Sr. Consultant in an full-time internal position at my employer for the last 3 1/2 years. I will now be able to help clients navigate the same intersection between the pharmaceutical supply chain, track and trace technology, standards and regulatory compliance that I have written about for the last three years.
Over those three years I have been approached by a number of companies who were looking for quality help with their special problems in this realm but I was forced to turn them down or refer them to other consultants because I already had a full time job. From now on I will be able to offer my own expertise instead.
I have pulled together a new website to market my services at www.DirkRodgers.com. So far it is pretty minimal but through the fall I intend to expand the information it contains and establish more formal offerings. If you know of someone in need of help with knowledge and strategy in the areas I write about, please refer them to either RxTrace.com or DirkRodgers.com.
SO NOW WHAT BECOMES OF RxTRACE?
The creation of a new website for marketing my consulting services was intentional. I don’t want RxTrace to change much at all. I promise not to turn it into a worthless repository of essays that simply tout my “consulting prowess”. I will maintain links between the two sites but I hope to keep the same range, focus and quality in the essays I post each week.
As if I didn’t have enough work to do in preparing a entire new website for Dirk Rodgers Consulting, my website design consultant, Matt Geiger and I have made a few updates on RxTrace.com at the same time. Matt is responsible for the new Dirk Rodgers Consulting logo, the new RxTrace Logo, the new header and the favicon. I think he’s done a fine job.
SUMMER, A TIME TO RELAX? NO, A TIME TO BUILD
So now you know what I’ve been doing with my summer so far. In a recent essay I hinted at relaxation. I wish. In addition to the work I talked about above I am also studying the FDA’s Unique Device Identification (UDI) proposed rule draft and I hope to have some comments on it in a couple of weeks. I have also signed up to deliver a webinar, work on some writing I can’t talk about yet, speak at two conferences and attend a number of others, all before the end of the year. But don’t worry. I’ll have plenty of time to do consulting work after July 27, 2012.
Stay tuned and thanks for reading.